HIV patients lose immunity to smallpox despite vaccination, AIDS drugs: Study

Image
Press Trust of India Washington
Last Updated : Jan 03 2020 | 2:20 PM IST

People infected with the Human Immunodeficiency Virus (HIV) lose immunity to smallpox even after much of their immune system is restored with drug therapy, according to a study which may lead to new interventions against opportunistic infections in HIV patients.

According to the researchers, including those from Oregon Health & Science University in the US, this condition called HIV-associated immune amnesia may explain why patients with AIDS tend to have shorter lives on average than their HIV-negative counterparts despite being on drug therapy.

The study, published in the Journal of Infectious Diseases, compared the immune system's T-cell, and antibody responses of a total of 100 HIV-positive and HIV-negative women who were vaccinated against smallpox in their youth.

Based on the findings, the researchers said the immune systems of HIV-positive women who were on antiretroviral drug therapy had a limited response when their blood was exposed to the 'vaccina virus' used in the smallpox vaccine.

They said those vaccinated against smallpox, normally have CD4 T cells that remember the virus and respond in large numbers when they're exposed again.

Earlier studies had revealed that the these immune cells specific to the smallpox virus are maintained for up to 75 years after vaccination.

But in the current study, despite antiretroviral therapy boosting CD4 T cell counts in HIV-positive patients, they were susceptible to smallpox infection.

According to the scientists, this indicates that while antiretroviral therapy may boost total T cell counts overall, it doesn't recover virus-specific T cells generated from prior childhood vaccinations.

The research team plans to evaluate whether the same findings apply for HIV-infected men, and if people living with HIV also lose immune memory to other diseases.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 03 2020 | 2:20 PM IST

Next Story